Japan Chemical Daily

Japan's leading chemical industry newspaper

Log In

Fujifilm Advances Development of Stem Cell-derived Regenerative Medicine

Filed Under: Innovation, Pharma Tagged With: , , , , , ,

Fujifilm Holdings Corp. (TYO:4901) subsidiary Cellular Dynamics International Inc. (CDI) is advancing development of regenerative medical products derived from induced…...

Please subscribe to read the full story.

Subscribe Free Trial

Related Articles:

Asahi Kasei Works on New iPS Treatments for Orthopedic Sector
Asahi Kasei Works on New iPS Treatments for Orthopedic…
LSII to Launch Clinical Trials of Muse Cells to Treat Respiratory Failure in COVID-19 Patients
LSII to Launch Clinical Trials of Muse Cells to Treat…
Keio University Venture Looks to Achieve Breakthrough in Cardiovascular Regenerative Medicine
Keio University Venture Looks to Achieve Breakthrough in…
Kyoto University Venture Thyas Uses iPS Cells to Generate Killer T Cells for Cancer Treatment
Kyoto University Venture Thyas Uses iPS Cells to Generate…
Mitsubishi Chemical to Produce Regenerative Medicine Materials From Plants
Mitsubishi Chemical to Produce Regenerative Medicine…
Sekisui Chemical Moves Into Cell Culture Sector
Sekisui Chemical Moves Into Cell Culture Sector